{"id":1287,"date":"2026-01-29T13:00:20","date_gmt":"2026-01-29T13:00:20","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/29\/ms-patients-report-feeling-better-after-a-year-of-biosimilar-treatment\/"},"modified":"2026-01-29T13:00:20","modified_gmt":"2026-01-29T13:00:20","slug":"ms-patients-report-feeling-better-after-a-year-of-biosimilar-treatment","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/01\/29\/ms-patients-report-feeling-better-after-a-year-of-biosimilar-treatment\/","title":{"rendered":"MS patients report feeling better after a year of biosimilar treatment"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/29\/ocrelizumab-biosimilar-linked-quality-life-gains-ms-study\/\" title=\"MS patients report feeling better after a year of biosimilar treatment\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2025\/04\/Doctor1-800x400.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A person speaks as a doctor, holding a clipboard, listens.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"148834\" \/><\/a><\/p>\n<p>People with multiple sclerosis (MS) reported improvements in physical and mental quality of life along with reduced depression after one year of treatment with an ocrelizumab biosimilar, according to a small study conducted in Iran. The observational study followed 30 adults with MS who received Xacrel, an ocrelizumab biosimilar approved in Iran, and assessed patient-reported [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/29\/ocrelizumab-biosimilar-linked-quality-life-gains-ms-study\/\">MS patients report feeling better after a year of biosimilar treatment<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/01\/29\/ocrelizumab-biosimilar-linked-quality-life-gains-ms-study\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>People with multiple sclerosis (MS) reported improvements in physical and mental quality of life along with reduced depression after one year of treatment with an ocrelizumab biosimilar, according to a small study conducted in Iran. The observational study followed 30 adults with MS who received Xacrel, an ocrelizumab biosimilar approved in Iran, and assessed patient-reported&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1288,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1287"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1288"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}